Women to Watch 2026: nominations now open to honour female pharmacy professionals
Help us find and celebrate brilliant, unrecognised women who are accomplishing great things in pharmacy.…
News
See all-
Cost of prescription items dispensed in community increases by 4% in a year
-
Regulator vows to prioritise racism review recommendations
-
NICE approves seladelpar for primary biliary cholangitis
-
PDA warns of ‘concerning’ decline in community pharmacists per pharmacy
-
Health news round up: diabetes, vaping and biologics
News from Wales
NICE approves seladelpar for primary biliary cholangitis
PJ view: Pharmacists on the new post-registration pathway will still need time and support to succeed
More than one-quarter of community pharmacies have designated sustainability champion, says GPhC
PJ view: The success of the royal college is a joint responsibility
Regulator opens consultation on one-year route to registration for overseas pharmacists
Fluoroquinolone prescribing in Wales reduced by over one-third over 12 months
Pharmacy regulator publishes AI position statement
News from Scotland
NICE approves seladelpar for primary biliary cholangitis
PJ view: Pharmacists on the new post-registration pathway will still need time and support to succeed
More than one-quarter of community pharmacies have designated sustainability champion, says GPhC
PJ view: The success of the royal college is a joint responsibility
Regulator opens consultation on one-year route to registration for overseas pharmacists
Fluoroquinolone prescribing in Wales reduced by over one-third over 12 months
Pharmacy regulator publishes AI position statement
Learning & CPD
Early-onset type 2 diabetes mellitus: identification and management
Adopting a personalised approach to resilience building in pharmacy
Psoriasis: presentation, diagnosis and management
Staying safe with online pharmacies: what patients and providers need to know about weight-loss prescribing
Clinical decision support tools in pharmacy practice
Pharmacy’s role in harm reduction in individuals with substance use disorder
Case-based learning: hyperpolypharmacy and pharmacist-led multidisciplinary continuity in primary care
Haemato-oncology
Bruton tyrosine kinase inhibitors and B-cell malignancies: a guide for pharmacists
Supported content
Chronic lymphocytic leukaemia: diagnosis and management
Supported content
How can pharmacists best support patients with chronic lymphocytic leukaemia?
Supported content
Management of Waldenstrom’s macroglobulinaemia
Supported content
BTK inhibitors: what pharmacists need to know
Supported content
BRUKINSA: explore the possibilities in CLL
Promotional contentWant to see content related to your country or pharmacy sector on your homepage? Visit your preference centre to update your interests and help us improve your digital experience.
Newly registered?
Find our dedicated career advice and resources, clinical CPD and professional skills content here.
Research
See all-
Preparing for pharmacist independent prescribing at scale
-
Addressing ethnic inequities in medication adherence
-
Chronic kidney disease: impacts, challenges and pathways to improvement
-
Testosterone in menopause: a review of the evidence and prescribing practice
-
Advantages and disadvantages of shorter antimicrobial courses
-
Pharmaceuticals from marine sources: past, present and future